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ABSTRACT 
Background: Methicillin-resistant Staphylococcus aureus (MRSA) is a common and continuously growing cause of nosocomial and 
community-acquired staphylococcal infections around the world. Screening for colonization with MRSA is a major aspect of control and 
limiting the spread of infections cause by this organism. We investigated the carriage of MRSA among apparently healthy individuals in 
four rural villages: Eleburu, Tapa, Atere and Apo all around semi-urban town-Malete, in Moro Local Government of Kwara State, Nigeria.  
Methods: Nasal swabs were collected from volunteered individuals and were cultured on mannitol salt agar and blood agar for isolation 
and identification of Staph aureus using standard microbiological techniques. Susceptibility to cefoxitin disc (30 µg) was used to determine 
MRSA status of the isolates. Molecular method was used to detect the gene responsible for resistance among MRSA isolates. Antimicrobial 
susceptibility test to commonly prescribed antibiotics was carried out using discs diffusion method.  
Results: Total number of individuals carrying Staph aureus in their nostrils was 42 (37.2 %). Antibiotics susceptibility profile of Staph 
aureus isolates showed 100 % resistance to cefuroxime, cefotaxime, cloxacillin and augmentin, and were 87 %, 81 %, 69 % and 23.8 % and 19 
% resistant to tetracycline, ceftriaxone, erythromycin, ofloxacin and gentamicin respectively. A total of 6 (14%) Community –Acquired 
MRSA (CA-MRSA) isolates were recovered from individuals living in these villages. Molecular method detected muc and mecA genes in all 
the 6 (100%) CA-MRSA isolates and lukS-lukF was detected in 3 (50%) of the isolates.  
Conclusion: Detection of CA-MRSA strains among these rural dweller indicates that they are harbouring enhance virulence organism that 
may manifest a more severe disease condition. The danger associated with high prevalence of multidrug resistant Staph aureus and CA-
MRSA; and its consequential effects of poor drug administration in Nigeria was discussed. There is need to establish a more strict 
legislation and enforcement on drug control; and a body that would monitor production and appropriate use of antibiotics in the Nigeria. 
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ABSTRAIT 
Contexte: Le Staphylococcus aureus résistant à la méthicilline (SARM) est une cause commune et en augmentation constante des infections staphylococciques 
nosocomiales et d'origine communautaire dans le monde. Le dépistage de la colonisation par le SARM est un aspect majeur du contrôle et de la limitation de la 
propagation des infections causées par cet organisme. Nous avons enquêté sur le transport de MRSA chez des individus apparemment en bonne santé dans 
quatre villages ruraux: Eleburu, Tapa, Atere et Apo tout autour d'une ville semi-urbaine-Malete, dans le gouvernement local de Moro dans l'État de Kwara, au 
Nigéria. 
Méthodes: Des écouvillons nasaux ont été prélevés sur des individus volontaires et ont été cultivés sur gélose au sel de mannitol et sur gélose au sang en vue de 
l'isolement et de l'identification de Staph aureus à l'aide de techniques microbiologiques standard. La sensibilité à la céfoxitine (30 µg) a été utilisée pour 
déterminer l’état de SARM des isolats. La méthode moléculaire a été utilisée pour détecter le gène responsable de la résistance parmi les isolats de SARM. Un 
test de sensibilité aux antimicrobiens aux antibiotiques couramment prescrits a été réalisé à l'aide de la méthode de diffusion sur disques.    Résultats: Le 
nombre total d'individus porteurs de Staph aureus dans leurs narines était de 42 (37,2%). Le profil de sensibilité aux antibiotiques des isolats de Staph aureus 
présentait une résistance à 100% au céfuroxime, au céfotaxime, à la cloxacilline et à l'augmentation, et à 87%, 81%, 69%, 23,8% et 19% respectivement. 






Au total, 6 isolats (14%) de SARM acquis dans la communauté (CA-SARM) ont été retrouvés chez des individus vivant dans ces villages.   La méthode 
moléculaire a détecté les gènes muc et mecA dans les 6 isolats (100%) de CA-MRSA et a détecté le lukS-lukF dans 3 (50%) des isolats. Conclusion: La 
détection de souches de SARM-CA chez ces habitants des zones rurales indique qu’elles hébergent un organisme de virulence qui pourrait se manifester par 
une maladie plus grave.                                                                                         
Le danger associé à la prévalence élevée de Staph aureus multirésistante et de CA-MRSA; et ses effets consécutifs à une mauvaise administration du 
médicament au Nigéria ont été discutés. Il est nécessaire de mettre en place une législation et une application plus strictes en matière de contrôle des drogues; 
et un organisme chargé de surveiller la production et l'utilisation appropriée des antibiotiques au Nigéria  
MOTS-CLÉS: SARMAC, Staph aureus, antibiotiques, villages ruraux et caractérisation moléculaire 
 
INTRODUCTION 
Methicillin-resistance Staph aureus (MRSA) refers to isolates 
of Staph aureus that are resistant to antibiotics with B-
lactam ring such as penicillins, cephalosporins and their 
derivatives from healthy individuals or patients. Staph 
aureus is an opportunistic pathogen that asymptomatically 
colonizing the nostrils, skin, glands and mucous membrane 
of both human and animal. It possesses a wide range of 
virulent factors and are responsible for a wide range of 
infections such as rashes, endovascular infections, 
inflammations of bones and the meninges, pneumonia, 
skin soft tissue infection (SSTIs), septic arthritis, 
endocarditis, sepsis, bloodstream infection and 
osteomyelitis [1], [2]. 
The first recorded emergence of methicillin resistance was 
in England in 1961 two years after introduction of 
methicillin [3]. MRSA organisms are also found to be 
resistant to other methicillin related antibiotics such as 
oxacillin, amoxicillin and penicillin. These organisms also 
acquire resistance to other groups of antibiotics that 
include clindamycin, cotrimoxazole, erythromycin and 
gentamicin [4]. The resistance is as a result of acquisition of 
resistant genes known as mec A gene which is a membrane-
bound enzymes that catalyzes the transpeptidation reaction 
and encodes the production of PBP-2a a penicillin-binding 
protein-2a which is essential for cross-linkage of 
peptidoglycan layer [5]. Lately, a new methicillin resistance 
gene known as mecC gene has been reported and MRSA 
carrying this gene has been isolated from both human and 
animal [6], [7], [8].   
Hospital acquired MRSA (HA-MRSA) has always been 
associated with prior exposure to hospitals and healthcare 
centres, however, recently MRSA infection in healthy 
individuals in community is on increase and it has been 
confirmed to be responsible for morbidity and mortality in 
various parts of the world [9], [10], and is referred to as 
community acquired methicillin-resistant Staph aureus (CA-
MRSA) [11], [12].  
HA-MRSA strains are genetically distinct from CA-MRSA, 
CA-MRSA strains are always resistant to the B-lactam and 
sometimes to erythromycin but largely remain susceptible 
to several other antibiotics. Many outbreaks of CA-MRSA 
have been reported in healthy populations and institutions 
such as Daycare centers, Military quarters and prisons [13]. 
Malete, a semi-urban town is surrounded by four rural 
villages; all are in Moro Local Government and Kwara 
North Senatorial District of Kwara State of Nigeria. These 
villages: Apo, Eleburu, Tapa and Atere have population of 
less than 500 each [14]. The residents are mainly farmers 
and herders. There are no schools or healthcare facilities in 
the villages. The pupils attend primary and secondary 
schools at Malete and the sick ones are cared for at Cottage 
Hospital, Malete. 
In Nigeria, there is paucity of information on MRSA, 
particularly CA-MRSA in rural and semi-urban 
populations with its antecedent danger of ignorance. In 
other to meet with this need, we investigated the carriage 
of CA-MRSA stains in the nostril of some apparently 
healthy individuals in rural communities of Malete, Kwara 
State. We also screened to detect genes responsible for 
MRSA in individuals that were positive to MRSA.   
MATERIALS AND METHODS 
Sample Collection 
Visits were made to each village heads (Baale) and his 
elders in council and obtained consent to collect nasal swab 
from only volunteered members of the villages. Further 
approval to carry out this research was obtained from 
Kwara State University research and ethical committee 
under the Community Development Centre (CDC). All 
subjects that have been admitted into the Hospital or 
Healthcare centre and those that were on any antimicrobial 
treatment in the past three months prior to sample 
collection were excluded from study. Samples were 
collected with sterile cotton swab pre-wetted with sterile 
saline; the swab was inserted into the two anterior nares 
and gently rotated. Samples were collected randomly from 
113 apparently healthy individuals in the four rural 
villages of Malete that included Apo, Eleburu, Atere and 
Tapa between first and third weeks of August, September 
and October, 2017.   
Culturing method 
Samples collected were transported in ice pack box within 
one hour of collection to the Microbiology laboratory, 
Department of Biosciences and Biotechnology, Kwara State 
University, Malete. The samples were cultured on mannitol 
salt agar and blood agar plates. They were incubated 
aerobically at 35-37 0C for 18-24 hours. On blood agar, 
colonies that were light yellow to whitish cream and were 
1-2 mm in diameter with some producing β-haemolysis or 
colonies on mannitol salt agar that were pinkish-yellow 






tests. Further tests carried out to confirm that the isolates 
were Staph aureus are Gram staining, catalase, coagulase 
and DNAse tests as previously described [15], [16]. 
Antimicrobial Susceptibility Test 
Antimicrobial susceptibility profile of each isolated Staph 
aureus was determined using standard disc diffusion 
method on Mueller-Hinton agar (Mast Diagnostics, Mast 
Group Ltd, Merseyside, UK) incubated aerobically at 37 0C 
for 18-24 hours using the following antibiotics discs; 
Cefuroxime (CXM30), Cefotaxime (CF30), Cloxacillin (CX5), 
Augmentin (AU30), Ceftriaxone (CRO30), Tetracycline 
(TE30), Erythromycin (E15), Gentamicin (GEN10) and 
Ofloxacin (OF5). Zones of inhibition were measured in 
millimeters and interpreted following criteria of the 
Clinical and Laboratory Standard Institute [17].  
Detection of Methicillin Resistance 
Resistance to methicillin was determined using disc 
diffusion susceptibility method as described by guideline 
of the [18]. This was performed with Cefoxitin30µg 
antibiotics disc (Oxoid, UK) on Mueller-Hinton agar plate 
(Mast Diagnostics, Mast Group Ltd, Merseyside, UK); 
where there are no zone of inhibition or zone radius 
measures 2 mm or less, isolates were regarded as resistant 
[18] 
Molecular Screening and Characterization 
The genomes of the isolates were extracted using QIAamp 
DNA Mini Kit according to manufacturer’s instructions. 
Methicillin resistant Staph aureus isolated that were 
phenotypically identified were subjected to molecular 
screening for the presence of muc gene [19] mecA gene, 
Panton valentine leucocidin (PVL) gene and lukS-lukF 
genes [19] using the appropriate primers as listed in Table 
1. The PCR condition were initiated for denaturation at 95 
oC for 2 minutes followed by 30 cycles of amplification 
with 94 oC for 30 minutes, annealing at 50 oC for 30 
seconds, extension at 72 oC for 30 seconds and final 
extension at 72 oC for 4 minutes. The PCR products (10 µg 
each for muc, mec and PVL genes) were analyzed in 1.5% 
agarose gel. Electrophoresis was performed in TBE buffer 
at 180 volts for 1 hour, and gel was subsequently stained 
with ethidium bromide (10 mg/ml) (Sigma, UK). DNA 
bands were visualized using UV-illuminator and 
photographed.  
RESULTS 
Distribution of Staph aureus among villages 
Staph aureus was recovered from the volunteered 
individuals from four rural villages studied. The total 
numbers of apparently healthy individuals carrying Staph 
aureus in their nostrils were 42 (37.2%) n=113; however the 
numbers recovered varied from one village (Table 2) to the 
other.  
  
TABLE 1: SEQUENCE OF PCR PRIMER SET FOR IDENTIFICATION OF STAPHYLOCOCCUS AUREUS, METHICILLIN RESISTANT 
GENES AND PVL GENE 
Target genes  primer set Primer sequence (5′→3′)  Amplicon 
Size (bp) 
















TABLE 2: STAPH AUREUS DISTRIBUTION IN VILLAGES 
Villages              Total Sample Collected                                               Staph aureus isolated 
                         Number                 Percentage (%)                     Number          Percentage (%)                             
Apo                    38                       34.0                                                 13                          34.2 
Eleburu              27                       24.0                                                  9                           33.3 
 Tapa                 23                       20.0                                                 12                          52.2 
Atere                  25                       22.0                                                  8                           32.0 








Resistance Profile of CA-MRSA isolates to antibiotics 
The percentage distribution of CA-MRSA showed that 42 
(100 %) were resistance to cefuroxime, cefotaxime, 
cloxacillin and augmentin, while 34 (80.9 %) were resistant 
to ceftriaxone, 35 (87.5 %) are resistant to tetracycline, 29 
(69.1 %) were resistant to erythromycin, 8 (19.1 %) were 
resistant to gentamicin and 10 (23.8 %) were resistant to 
ofloxacin. 
Molecular analysis of the isolated MRSA 
Molecular analysis on the 6 isolates that were methicillin 
resistant Staph aureus showed that muc and mec A genes 
were detected in all the 6 isolates (Plates 1; 2). While only 3 
of the six Methicillin resistant isolates had lukS-lukF (Plate 
3) and only 3 of the six methicillin resistant Staph aureus 
isolates had PVL gene detected (Plates 3). 
 













   
 
 
PLATE 2: PCR PRODUCTS AFTER GEL ELECTROPHORESIS SHOWING AMPLICONS FOR MEC A (535BP). 






        215bp 




































PLATE 3: PCR PRODUCTS AFTER GEL ELECTROPHORESIS SHOWING AMPLICON FOR PVL GENE DETECTED IN 
ONLY THREE OUT OF SIX CA-MRSA ISOLATED FROM MALETE COMMUNITIES. DNA MOLECULAR WEIGHT MARKER (M) 
(435BP) 
 
DISCUSSION                                                                                  
Community acquired methicillin-resistant Staphylococcus 
aureus (CA-MRSA) has emerged as an important human 
pathogen in various parts of the world. This pathogen has 
varied distribution in both urban and rural community 
settings. In this study, we reported a prevalence of 37.2 % 
of Staph aureus in nostrils of apparently healthy individuals 
in rural communities of Malete. This prevalence is lower 
than a prevalence of 56.3 % reported by Chibuike and 
colleagues [20] in rural communities of Ururu among 
healthy individuals. Also a lower prevalence of 36.5 and 
13.9% were reported by Egwuata et al. [21] in health 
workers in Lagos and Okwu et al. [22] among healthy 
individuals in Okada, Edo State Nigeria respectively. 
Various authors have recommended eradication of nasal 
carriage of Staph aureus to reduce transmission to others 
with the use of systemic antimicrobials, normal bacterial 
flora augmentation, antiseptic washes and topical 
antimicrobials [23], [24]. 
Antimicrobial resistance is one of the major threat posed by 
microorganisms to infection management in this twenty 
first century and Staph aureus has always been one of the 
major pathogen that possess ability to develop resistance to 
newly developed antimicrobial agents [25]. In this study, 
Staph aureus isolated were resistant to commonly available 
and recommended antibiotics such as cefuroxime, 
cefotaxime, cloxacillin and augmentin, but susceptible to 
ceftriaxone, tetracycline, erythromycin, gentamicin and 
ofloxacin in varying degrees. Susceptibility of 
erythromycin ranges from 5 to 64% in different geographic 
areas [26], while the susceptibility in this study is 30.9 %. 
There are many factors that may be adduced to the high 
resistance of this organism to antibiotics in these rural 
communities. Such factors included self-medication, 
availability and use of antibiotics without Doctor’s 
prescription, irrational consumption rate of antibiotics, 
noncompliance to prescription and sales of fake or 
substandard drugs and transmission of resistant strains 
between individuals within the community. 
Methicillin resistance is mediated among Staph aureus by 
the penicillin-binding protein (PBP)- 2a encoded by mecA 
gene. It was reported that all β-lactam antibiotics have poor 
affinity when PBP is altered, and such microbe would not 
be killed when exposed to therapeutic concentration. The 
mecA gene is found to be located on a mobile genetic 
element of staphylococcal chromosome cassette (SCCmec) 
[27]. In this study, the prevalence of methicillin resistance 
Staph aureus was 14.3 %. This is prevalence is lower when 
compared with what other researchers reported among 
apparently healthy individuals. Prevalence of 22.0, 47.6 and 
60.6 % were reported by Akerele et al. [28] in Ekosundun, 
Benin City; Adelowo et al. [29] in Maiduguri and Chibuike 
et al. [21] in Uturu rural community respectively.    
The major objective of screening for mecA gene is to 
compare results of antibiotic susceptibility by disc diffusion 
method with gene analysis results in Staph aureus isolates. 
The phenotypic expression of antibiotic resistant genes has 
been reported to be affected by different conditions such as 
the incubation temperature and time, medium inoculated, 
inoculum size, test agents, pH, and ionic strength of NaCl 
[30]. The mecA gene may be heterogeneously expressed 
and, therefore, all MRSA strains may not be detectable with 
phenotypical methods and the test require at least 24 h for 
evaluation of the results. However, the detection of mecA 
gene by PCR techniques is considered the gold standard 
method. All the six isolates that were cefoxitin resistant 







confirming that they are all methicillin-resistant Staph 
aureus 
The present study showed strong correlation between 
genotypic and phenotypic analysis, the results were 
consistent with previous studies which showed a perfect 
and strong correlation between the results obtained by the 
phenotypic antibiotic resistance determination and PCR-
based assays [31], [32]. The critical parameters for success 
of a PCR-based assay for the detection of multidrug 
resistant bacteria like MRSA are the reliability, accuracy, 
fast and sensitivity and results were obtained within hours 
[33]. However the cefoxitin disc has been shown to have 
specificity 97-100 % to detected mec A gene [34]. 
Previous reports on MRSA in North-central, Nigeria were 
based phenotypic method, to our best knowledge this is the 
first report based on the detection of mecA gene in CA-
MRSA among healthy individuals in rural communities of 
North-central, Nigeria. However, mecA gene has been 
discovered from other different part of Nigeria such reports 
included, a study in Benin city, Nigeria, 4 isolates 
representing 11 % were confirmed to carry mecA gene using 
molecular technique [35], Esan et al. [36] confirmed only one 
MRSA isolate from health care institutions from Ekiti and 
Ondo states and Shittu et al. [37],  detected two MRSA 
isolates with mecA gene were detected in Ile-Ife, one from 
Lagos and two from Ibadan (all in South-western Nigeria) 
In the North-eastern Nigeria, five MRSA isolates with mec A 
gene were detected in Maiduguri by Okon et al. [38] 
reported the detection of 12.5 % MRSA from clinical 
specimens from six tertiary hospitals.  
PCR result for the detection PVL (lukS-lukF) gene in this 
research showed that out of 6 MRSA isolates screened only 3 
of them were PVL positive, representing a percentage  of 50 
% (n=6). This finding was higher compared to the report of 
Sani et al. [39] who detected PVL gene prevalence of 3.25 and 
8.13 % amongst MRSA from hospitalized and non-
hospitalized patients in Benin. However, this difference may 
be due to the size of our samples. Another report by Breurec 
et al. [40] detected a 57 % lukS-lukF genes encoding Panton–
Valentine Leukocidin (PVL) prevalent in MRSA isolates 
from Cameroon, Niger, and Senegal (West and Central 
Africa).  
It appears that misuse and overuse of these antibiotics could 
have contributed to increase in antibiotics resistance in these 
rural communities as it has been observed in other part of 
the world. Therefore, to prevent resistance and treatment 
failures, we advocate   proper monitoring of antibiotics 
usage and collection of data on antibiotic susceptibility 
testing pattern, public enlightenment on the effectiveness of 
various antibiotics and the enactment of drug policies in 
Nigeria; are urgently needed to move in line with the global 
trends.   
Multidrug resistant organisms are defined as organisms that 
have acquired non-susceptibility to at least one agent in 
three or more classes of antimicrobial [41], [42], [43], [44]. By 
this definition, all the six CA-MRSA isolated in this 
community are multidrug resistant Staph aureus.  
 
Conclusion: The detection of methicillin-resistant Staph 
aureus carriage among individuals in these remote rural 
communities of Malete indicated the extensive distribution 
of this organism and also indicated that the abuse of drug is 
on high side in Nigeria. Unlicensed patent medicine dealer 
and drug hawkers may be the main source of drugs 
distribution to these villages.  
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